Share This Author
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
During the past several decades, there has been a steady increase in the frequency of opportunistic invasive fungal infections (IFIs) in immunocompromised patients. However, there is substantial…
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- S. Lockhart, K. Etienne, A. Litvintseva
- Medicine, BiologyClinical infectious diseases : an official…
- 15 January 2017
Candida auris is an emerging healthcare-associated pathogen associated with high mortality, and WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents.
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research…
These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
- R. Agarwal, A. Chakrabarti, D. Denning
- Medicine, BiologyClinical and experimental allergy : journal of…
- 1 August 2013
The importance of recognizing ABPA relates to the improvement of patient symptoms, and delay in development or prevention of bronchiectasis, one manifestation of permanent lung damage in ABPA.
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research…
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
First hospital outbreak of the globally emerging Candida auris in a European hospital
- S. Schelenz, F. Hagen, M. Fisher
- Medicine, BiologyAntimicrobial Resistance & Infection Control
- 19 October 2016
This ongoing outbreak with genotypically closely related C. auris highlights the importance of appropriate species identification and rapid detection of cases in order to contain hospital acquired transmission.
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its…
- S. Kathuria, Pradeep K. Singh, A. Chowdhary
- Biology, MedicineJournal of Clinical Microbiology
- 25 March 2015
A cautionary approach is recommended for laboratories relying on commercial systems for identification and antifungal susceptibility testing of rare yeasts, as 90% of the isolates characterized by commercial identification systems are misidentified as C. auris.
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.
- M. Arendrup, T. Boekhout, M. Akova, J. Meis, O. Cornely, O. Lortholary
- Biology, MedicineClinical microbiology and infection : the…
- 1 April 2014
Recommendations about the microbiological investigation and detection of invasive infection were made and current knowledge on the most appropriate antifungal and supportive treatment was reviewed.